• Thu, April 4, 2024

by: WOPRAI

Brian Lee Maintained (AYI) at Hold with Increased Target to $261 on, Apr 4th, 2024

by: WOPRAI

Matthew Stanton Initiated (AZTA) at Hold and Held Target at $64 on, Apr 4th, 2024

by: WOPRAI

Vijay Kumar Maintained (AZTA) at Hold with Decreased Target to $60 on, Apr 4th, 2024

by: WOPRAI

Erika Najarian Downgraded (BAC) to Hold and Increased Target to $40 on, Apr 4th, 2024

by: WOPRAI

Glenn Schorr Maintained (BAC) at Buy with Increased Target to $41 on, Apr 4th, 2024

by: WOPRAI

Michael Leithead Downgraded (BALL) to Hold and Increased Target to $71 on, Apr 4th, 2024

by: WOPRAI

Paul Treiber Reiterated (BB) at Hold and Held Target at $3 on, Apr 4th, 2024

by: WOPRAI

Mark Massaro Maintained (ADPT) at Strong Buy with Decreased Target to $5 on, Apr 4th, 2024

by: WOPRAI

Bose George Maintained (ACT) at Buy with Increased Target to $37 on, Apr 4th, 2024

by: WOPRAI

Amit Dayal Reiterated (AMPX) at Strong Buy and Held Target at $10 on, Apr 4th, 2024

by: WOPRAI

Anthony Pettinari Maintained (AVY) at Hold with Increased Target to $234 on, Apr 4th, 2024

by: WOPRAI

Vijay Kumar Maintained (AVTR) at Buy with Increased Target to $28 on, Apr 4th, 2024

by: WOPRAI

Charles Duncan Reiterated (ATAI) at Buy on, Apr 4th, 2024

by: WOPRAI

Vikram Gandhi Downgraded (CB) to Hold and Decreased Target to $270 on, Apr 4th, 2024

by: WOPRAI

Kyle Voigt Maintained (CBOE) at Hold and Held Target at $197 on, Apr 4th, 2024

by: WOPRAI

Lizzie Dove Upgraded (CAR) to Hold and Increased Target to $130 on, Apr 4th, 2024

by: WOPRAI

Matthew Akers Maintained (CACI) at Buy with Increased Target to $410 on, Apr 4th, 2024

by: WOPRAI

Samantha Semenkow Maintained (CABA) at Strong Buy with Increased Target to $30 on, Apr 4th, 2024

by: WOPRAI

Brandon Nispel Maintained (CABO) at Buy with Decreased Target to $881 on, Apr 4th, 2024

by: WOPRAI

Carter Gould Maintained (BIIB) at Hold with Decreased Target to $215 on, Apr 4th, 2024

by: WOPRAI

Bill Carcache Upgraded (BFH) to Buy and Held Target at $48 on, Apr 4th, 2024

by: WOPRAI

Ross Fowler Downgraded (CMS) to Hold and Held Target at $65 on, Apr 4th, 2024

by: WOPRAI

Steven Alexopoulos Maintained (CFR) at Buy with Increased Target to $140 on, Apr 4th, 2024

by: WOPRAI

Durgesh Chopra Maintained (CEG) at Buy with Increased Target to $198 on, Apr 4th, 2024

by: WOPRAI

Jeffrey Zekauskas Downgraded (CE) to Sell and Increased Target to $160 on, Apr 4th, 2024

by: WOPRAI

Michael Leithead Downgraded (CE) to Hold and Held Target at $170 on, Apr 4th, 2024

by: WOPRAI

Asiya Merchant Maintained (CDW) at Strong Buy with Increased Target to $295 on, Apr 4th, 2024

by: WOPRAI

Clarke Jeffries Initiated (CDNS) at Hold and Held Target at $334 on, Apr 4th, 2024

by: WOPRAI

Matthew Akers Maintained (SPCE) at Sell with Decreased Target to $20 on, Apr 4th, 2024

by: WOPRAI

Anthony Pettinari Maintained (SON) at Strong Buy with Decreased Target to $65 on, Apr 4th, 2024

by: WOPRAI

Daniel Ford Downgraded (SO) to Hold and Decreased Target to $76 on, Apr 4th, 2024

by: WOPRAI

Steven Alexopoulos Maintained (SNV) at Buy with Increased Target to $50 on, Apr 4th, 2024

by: WOPRAI

Clarke Jeffries Initiated (SNPS) at Buy and Held Target at $665 on, Apr 4th, 2024

by: WOPRAI

Andrea Teixeira Initiated (SN) at Buy and Held Target at $70 on, Apr 4th, 2024

by: WOPRAI

Vijay Kumar Maintained (SYK) at Buy with Increased Target to $370 on, Apr 4th, 2024

by: WOPRAI

Bill Carcache Upgraded (SYF) to Buy and Increased Target to $50 on, Apr 4th, 2024

by: WOPRAI

Glenn Schorr Maintained (STT) at Buy with Increased Target to $88 on, Apr 4th, 2024

by: WOPRAI

Charles Duncan Reiterated (STOK) at Buy on, Apr 4th, 2024

by: WOPRAI

Jason Gursky Maintained (TDG) at Strong Buy on, Apr 4th, 2024

by: WOPRAI

Steven Alexopoulos Maintained (TCBI) at Sell with Decreased Target to $65 on, Apr 4th, 2024

by: WOPRAI

Michael Rose Downgraded (TCBI) to Hold on, Apr 4th, 2024

by: WOPRAI

Eric Schmidt Initiated (TNGX) at Buy on, Apr 4th, 2024

by: WOPRAI

Vijay Kumar Maintained (TMO) at Buy with Increased Target to $610 on, Apr 4th, 2024

by: WOPRAI

David Saxon Reiterated (STAA) at Hold on, Apr 4th, 2024

by: WOPRAI

James Faucette Downgraded (SQ) to Sell and Decreased Target to $60 on, Apr 4th, 2024

by: WOPRAI

Mark Palmer Maintained (SQ) at Strong Buy with Increased Target to $99 on, Apr 4th, 2024

by: WOPRAI

Peter Benedict Maintained (SPWH) at Hold with Decreased Target to $4 on, Apr 4th, 2024

by: WOPRAI

Eric Wold Maintained (SPWH) at Hold with Decreased Target to $4 on, Apr 4th, 2024

Roy Buchanan Reiterated (ABUS) at Buy and Held Target at $4 on, Apr 4th, 2024

Roy Buchanan of JMP Securities, Reiterated "Arbutus Biopharma Corporation" (ABUS) at Buy and Held Target at $4 on, Apr 4th, 2024.

Roy has made no other calls on ABUS in the last 4 months.



There are 2 other peers that have a rating on ABUS. Out of the 2 peers that are also analyzing ABUS, 0 agree with Roy's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Roy

  • Ed Arce of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $5 on, Friday, March 1st, 2024
  • Keay Nakae of "Chardan Capital" Reiterated at Strong Buy and Held Target at $4 on, Friday, March 1st, 2024